Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.67 B1.74 B1.88 B2.06 B2.16 B 7.84 B Research & development ————— — Operating income 1.42 B1.39 B1.65 B1.68 B1.63 B 6.35 B Non-Operating Income, Total -406 M-1.53 B-1.78 B-1.31 B-1.25 B -5.87 B Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses -406 M-1.53 B-1.78 B-1.31 B-1.25 B -5.87 B Unusual income/expense ————— — Pretax income 1.35 B980 M1.21 B1.12 B1.51 B 4.81 B Equity in earnings 267 M238 M620 M429 M533 M 1.82 B Taxes 404 M245 M308 M301 M345 M 1.2 B Non-controlling/minority interest 5 M6 M6 M7 M-23 M -4 M After tax other income/expense ————— — Net income before discontinued operations 945 M729 M896 M809 M1.19 B 3.62 B Discontinued operations ————— — Net income 945 M729 M896 M809 M1.19 B 3.62 B Dilution adjustment ——-66 M-31 M— — Preferred dividends ——12 M0— — Diluted net income available to common stockholders 879 M698 M818 M778 M1.14 B 3.43 B Basic earnings per share (Basic EPS) 1.291.041.231.181.75 5.2 Diluted earnings per share (Diluted EPS) 1.281.031.221.181.74 5.17 Average basic shares outstanding 682.3 M670.8 M664.7 M668.9 M652 M — Diluted shares outstanding 687 M675 M669.1 M673.3 M655.7 M — EBITDA 1.47 B562 M448 M793 M1.42 B 3.22 B EBIT 915 M-1 M-110 M129 M817 M 835 M Cost of revenue 14.3 B14.02 B13.96 B20 B14.46 B 62.45 B Other cost of goods sold 161 M158 M273 M245 M199 M 875 M Depreciation & amortization (cash flow) 554 M563 M558 M664 M603 M 2.39 B